Search This Blog

Thursday, May 9, 2019

Blueprint Medicines reports Q1 EPS ($1.98), consensus ($1.86)

Reports Q1 revenue $730K, consensus $1.7M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.